ID   ROR1_HUMAN              Reviewed;         937 AA.
AC   Q01973; Q5VVX6; Q66K77; Q92776;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Inactive tyrosine-protein kinase transmembrane receptor ROR1 {ECO:0000305};
DE   AltName: Full=Neurotrophic tyrosine kinase, receptor-related 1;
DE   Flags: Precursor;
GN   Name=ROR1; Synonyms=NTRKR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND VARIANT MET-518.
RX   PubMed=1334494;
RA   Masiakowski P., Carroll R.D.;
RT   "A novel family of cell surface receptors with tyrosine kinase-like
RT   domain.";
RL   J. Biol. Chem. 267:26181-26190(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RX   PubMed=8875995;
RA   Reddy U.R., Phatak S., Pleasure D.;
RT   "Human neural tissues express a truncated Ror1 receptor tyrosine
RT   kinase, lacking both extracellular and transmembrane domains.";
RL   Oncogene 13:1555-1559(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   LACK OF CATALYTIC ACTIVITY, AND MUTAGENESIS OF CYS-482.
RX   PubMed=25029443; DOI=10.1371/journal.pone.0102695;
RA   Bainbridge T.W., DeAlmeida V.I., Izrael-Tomasevic A., Chalouni C.,
RA   Pan B., Goldsmith J., Schoen A.P., Quinones G.A., Kelly R., Lill J.R.,
RA   Sandoval W., Costa M., Polakis P., Arnott D., Rubinfeld B.,
RA   Ernst J.A.;
RT   "Evolutionary divergence in the catalytic activity of the CAM-1, ROR1
RT   and ROR2 kinase domains.";
RL   PLoS ONE 9:E102695-E102695(2014).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-562.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-144; LEU-150; VAL-301; MET-518;
RP   ILE-567; ARG-624; CYS-646 AND ASN-776.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Has very low kinase activity in vitro and is unlikely to
CC       function as a tyrosine kinase in vivo. May act as a receptor for
CC       wnt ligand WNT5A which may result in the inhibition of WNT3A-
CC       mediated signaling. {ECO:0000269|PubMed:25029443}.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=8; IntAct=EBI-6082337, EBI-297353;
CC       P12931:SRC; NbExp=9; IntAct=EBI-6082337, EBI-621482;
CC       P05480:Src (xeno); NbExp=3; IntAct=EBI-6082337, EBI-298680;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Long;
CC         IsoId=Q01973-1; Sequence=Displayed;
CC       Name=Short; Synonyms=T-ROR1;
CC         IsoId=Q01973-2; Sequence=VSP_005008;
CC       Name=3;
CC         IsoId=Q01973-3; Sequence=VSP_043663, VSP_043664;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed strongly in human heart, lung and
CC       kidney, but weakly in the CNS. Isoform Short is strongly expressed
CC       in fetal and adult CNS and in a variety of human cancers,
CC       including those originating from CNS or PNS neuroectoderm.
CC   -!- DEVELOPMENTAL STAGE: Expressed at high levels during early
CC       embryonic development. The expression levels drop strongly around
CC       day 16 and there are only very low levels in adult tissues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. ROR subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- CAUTION: The kinase domain has very low catalytic activity in
CC       vitro. {ECO:0000269|PubMed:25029443}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97675; AAA60275.1; -; mRNA.
DR   EMBL; U38894; AAC50714.1; -; mRNA.
DR   EMBL; AL137859; CAC17591.2; -; Genomic_DNA.
DR   EMBL; AL161742; CAC17591.2; JOINED; Genomic_DNA.
DR   EMBL; AL445205; CAC17591.2; JOINED; Genomic_DNA.
DR   EMBL; AL445205; CAH71705.1; -; Genomic_DNA.
DR   EMBL; AL137859; CAH71705.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAH71705.1; JOINED; Genomic_DNA.
DR   EMBL; AL445205; CAH71706.1; -; Genomic_DNA.
DR   EMBL; AL137859; CAH71706.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAH71706.1; JOINED; Genomic_DNA.
DR   EMBL; AL137859; CAI21732.1; -; Genomic_DNA.
DR   EMBL; AL445205; CAI21732.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAI21732.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAI21931.1; -; Genomic_DNA.
DR   EMBL; AL137859; CAI21931.1; JOINED; Genomic_DNA.
DR   EMBL; AL445205; CAI21931.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAI21932.1; -; Genomic_DNA.
DR   EMBL; AL445205; CAI21932.1; JOINED; Genomic_DNA.
DR   EMBL; AL137859; CAI21932.1; JOINED; Genomic_DNA.
DR   EMBL; AL138793; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353713; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL808029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL808030; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06556.1; -; Genomic_DNA.
DR   EMBL; BC080541; AAH80541.1; -; mRNA.
DR   CCDS; CCDS41344.1; -. [Q01973-3]
DR   CCDS; CCDS626.1; -. [Q01973-1]
DR   PIR; A45082; A45082.
DR   RefSeq; NP_001077061.1; NM_001083592.1. [Q01973-3]
DR   RefSeq; NP_005003.2; NM_005012.3. [Q01973-1]
DR   UniGene; Hs.128753; -.
DR   ProteinModelPortal; Q01973; -.
DR   SMR; Q01973; -.
DR   BioGrid; 110973; 7.
DR   DIP; DIP-29734N; -.
DR   IntAct; Q01973; 9.
DR   MINT; MINT-5004457; -.
DR   STRING; 9606.ENSP00000360120; -.
DR   iPTMnet; Q01973; -.
DR   PhosphoSitePlus; Q01973; -.
DR   SwissPalm; Q01973; -.
DR   BioMuta; ROR1; -.
DR   DMDM; 118572711; -.
DR   EPD; Q01973; -.
DR   MaxQB; Q01973; -.
DR   PaxDb; Q01973; -.
DR   PeptideAtlas; Q01973; -.
DR   PRIDE; Q01973; -.
DR   DNASU; 4919; -.
DR   Ensembl; ENST00000371079; ENSP00000360120; ENSG00000185483. [Q01973-1]
DR   Ensembl; ENST00000371080; ENSP00000360121; ENSG00000185483. [Q01973-3]
DR   GeneID; 4919; -.
DR   KEGG; hsa:4919; -.
DR   UCSC; uc001dbi.5; human. [Q01973-1]
DR   CTD; 4919; -.
DR   DisGeNET; 4919; -.
DR   GeneCards; ROR1; -.
DR   HGNC; HGNC:10256; ROR1.
DR   HPA; HPA057016; -.
DR   MIM; 602336; gene.
DR   neXtProt; NX_Q01973; -.
DR   OpenTargets; ENSG00000185483; -.
DR   PharmGKB; PA34628; -.
DR   eggNOG; ENOG410IMMJ; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118818; -.
DR   HOVERGEN; HBG017736; -.
DR   InParanoid; Q01973; -.
DR   KO; K05122; -.
DR   OMA; WAEFQQE; -.
DR   OrthoDB; EOG091G02W3; -.
DR   PhylomeDB; Q01973; -.
DR   TreeFam; TF106465; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   SignaLink; Q01973; -.
DR   SIGNOR; Q01973; -.
DR   ChiTaRS; ROR1; human.
DR   GeneWiki; ROR1; -.
DR   GenomeRNAi; 4919; -.
DR   PRO; PR:Q01973; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185483; -.
DR   CleanEx; HS_ROR1; -.
DR   ExpressionAtlas; Q01973; baseline and differential.
DR   Genevisible; Q01973; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:1904929; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:UniProtKB.
DR   GO; GO:0014002; P:astrocyte development; IEA:Ensembl.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc.
DR   Gene3D; 1.10.2000.10; -; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR016247; Tyr_kinase_rcpt_ROR.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF000624; TyrPK_TMrec_ROR; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00130; KR; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Kringle; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Wnt signaling pathway.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30    937       Inactive tyrosine-protein kinase
FT                                transmembrane receptor ROR1.
FT                                /FTId=PRO_0000024458.
FT   TOPO_DOM     30    406       Extracellular. {ECO:0000255}.
FT   TRANSMEM    407    427       Helical. {ECO:0000255}.
FT   TOPO_DOM    428    937       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       42    147       Ig-like C2-type.
FT   DOMAIN      165    299       FZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00090}.
FT   DOMAIN      312    391       Kringle. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      473    746       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     479    487       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    753    782       Ser/Thr-rich.
FT   COMPBIAS    784    851       Pro-rich.
FT   COMPBIAS    853    876       Ser/Thr-rich.
FT   BINDING     506    506       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     645    645       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    315    315       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     79    131       {ECO:0000250}.
FT   DISULFID    170    235       {ECO:0000250}.
FT   DISULFID    178    228       {ECO:0000250}.
FT   DISULFID    219    260       {ECO:0000250}.
FT   DISULFID    248    296       {ECO:0000250}.
FT   DISULFID    252    282       {ECO:0000250}.
FT   DISULFID    313    391       {ECO:0000250}.
FT   DISULFID    334    374       {ECO:0000250}.
FT   DISULFID    362    386       {ECO:0000250}.
FT   VAR_SEQ       1    549       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:8875995}.
FT                                /FTId=VSP_005008.
FT   VAR_SEQ     392    393       DS -> GK (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043663.
FT   VAR_SEQ     394    937       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043664.
FT   VARIANT     144    144       G -> E (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041779.
FT   VARIANT     150    150       F -> L (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041780.
FT   VARIANT     301    301       I -> V (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041781.
FT   VARIANT     518    518       T -> M (in dbSNP:rs7527017).
FT                                {ECO:0000269|PubMed:1334494,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041782.
FT   VARIANT     562    562       E -> D (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035713.
FT   VARIANT     567    567       R -> I (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041783.
FT   VARIANT     624    624       G -> R (in dbSNP:rs55832740).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041784.
FT   VARIANT     646    646       Y -> C (in dbSNP:rs34109134).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041785.
FT   VARIANT     776    776       S -> N (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041786.
FT   MUTAGEN     482    482       C->G: No effect on kinase activity.
FT                                {ECO:0000269|PubMed:25029443}.
SQ   SEQUENCE   937 AA;  104283 MW;  0EC0E4762A90C6C7 CRC64;
     MHRPRRRGTR PPLLALLAAL LLAARGAAAQ ETELSVSAEL VPTSSWNISS ELNKDSYLTL
     DEPMNNITTS LGQTAELHCK VSGNPPPTIR WFKNDAPVVQ EPRRLSFRST IYGSRLRIRN
     LDTTDTGYFQ CVATNGKEVV SSTGVLFVKF GPPPTASPGY SDEYEEDGFC QPYRGIACAR
     FIGNRTVYME SLHMQGEIEN QITAAFTMIG TSSHLSDKCS QFAIPSLCHY AFPYCDETSS
     VPKPRDLCRD ECEILENVLC QTEYIFARSN PMILMRLKLP NCEDLPQPES PEAANCIRIG
     IPMADPINKN HKCYNSTGVD YRGTVSVTKS GRQCQPWNSQ YPHTHTFTAL RFPELNGGHS
     YCRNPGNQKE APWCFTLDEN FKSDLCDIPA CDSKDSKEKN KMEILYILVP SVAIPLAIAL
     LFFFICVCRN NQKSSSAPVQ RQPKHVRGQN VEMSMLNAYK PKSKAKELPL SAVRFMEELG
     ECAFGKIYKG HLYLPGMDHA QLVAIKTLKD YNNPQQWTEF QQEASLMAEL HHPNIVCLLG
     AVTQEQPVCM LFEYINQGDL HEFLIMRSPH SDVGCSSDED GTVKSSLDHG DFLHIAIQIA
     AGMEYLSSHF FVHKDLAARN ILIGEQLHVK ISDLGLSREI YSADYYRVQS KSLLPIRWMP
     PEAIMYGKFS SDSDIWSFGV VLWEIFSFGL QPYYGFSNQE VIEMVRKRQL LPCSEDCPPR
     MYSLMTECWN EIPSRRPRFK DIHVRLRSWE GLSSHTSSTT PSGGNATTQT TSLSASPVSN
     LSNPRYPNYM FPSQGITPQG QIAGFIGPPI PQNQRFIPIN GYPIPPGYAA FPAAHYQPTG
     PPRVIQHCPP PKSRSPSSAS GSTSTGHVTS LPSSGSNQEA NIPLLPHMSI PNHPGGMGIT
     VFGNKSQKPY KIDSKQASLL GDANIHGHTE SMISAEL
//
